Robert Anthony Huddart
Impact in
- Surgery top 0.05%
- Testicular diseases and treatments
- Bladder and Urothelial Cancer Treatments
- Urinary and Genital Oncology Studies
- Pulmonary and Respiratory Medicine top 0.2%
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
Papers in
- Surgery 256
- Testicular diseases and treatments 152
- Bladder and Urothelial Cancer Treatments 92
- Urinary and Genital Oncology Studies 30
-
- Prostate Cancer Diagnosis and Treatment 47
- Sarcoma Diagnosis and Treatment 32
- Prostate Cancer Treatment and Research 29
- Co-authors
- David Paul Dearnaley (87 shared papers)A. Horwich (57 shared papers)Andrew Richard Norman (28 shared papers)Alan Horwich (41 shared papers)JANET M. SHIPLEY (20 shared papers)Emma Hall (46 shared papers)Chris C. Parker (43 shared papers)Vincent S Khoo (33 shared papers)
- Journals
- Clinical Oncology (56 papers)Annals of Oncology (36 papers)International Journal of Radiation Oncology*Biology*Physics (27 papers)British Journal of Cancer (26 papers)European Urology (19 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Robert Anthony Huddart
419 papers receiving 24.1k citations
Robert Anthony Huddart's Hit Papers
Peers
Comparison fields: 5 of 160
- Surgery 11.6k
- Pulmonary and Respiratory Medicine 6.7k
- Reproductive Medicine 1.7k
- Radiation 1.5k
- Oncology 3.4k
Countries citing papers authored by Robert Anthony Huddart
This map shows the geographic impact of Robert Anthony Huddart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Anthony Huddart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Anthony Huddart more than expected).
Fields of papers citing papers by Robert Anthony Huddart
This network shows the impact of papers produced by Robert Anthony Huddart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Anthony Huddart. The network helps show where Robert Anthony Huddart may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Anthony Huddart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 430 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma Hit paper breakdown → | 2019 | 1055 |
| 2 | Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial Hit paper breakdown → | 2007 | 747 |
| 3 | Multiple newly identified loci associated with prostate cancer susceptibility Hit paper breakdown → | 2008 | 723 |
| 4 | Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer Hit paper breakdown → | 2012 | 717 |
| 5 | Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial Hit paper breakdown → | 2021 | 488 |
| 6 | 2005 | 470 | |
| 7 | Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System) Hit paper breakdown → | 2018 | 463 |
| 8 | 2013 | 460 | |
| 9 | European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I Hit paper breakdown → | 2008 | 447 |
| 10 | 2003 | 442 | |
| 11 | Stereotactic body radiotherapy for oligometastases Hit paper breakdown → | 2012 | 424 |
| 12 | Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Hit paper breakdown → | 2021 | 397 |
| 13 | Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial Hit paper breakdown → | 2014 | 384 |
| 14 | 2009 | 354 | |
| 15 | 2004 | 347 | |
| 16 | 2006 | 324 | |
| 17 | 2005 | 322 | |
| 18 | 2010 | 292 | |
| 19 | 2002 | 281 | |
| 20 | 2009 | 277 |
About Robert Anthony Huddart
Robert Anthony Huddart is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Radiation, Reproductive Medicine and Oncology, having authored 430 papers that have together received 24.8k indexed citations. Recurring topics across this work include Testicular diseases and treatments (152 papers), Bladder and Urothelial Cancer Treatments (92 papers), Advanced Radiotherapy Techniques (51 papers), Prostate Cancer Diagnosis and Treatment (47 papers), Sarcoma Diagnosis and Treatment (32 papers), Sexual Differentiation and Disorders (31 papers), Urinary and Genital Oncology Studies (30 papers) and Prostate Cancer Treatment and Research (29 papers). The work is most often cited by research in Surgery (11.6k citations), Pulmonary and Respiratory Medicine (6.7k citations), Reproductive Medicine (1.7k citations), Radiation (1.5k citations) and Oncology (3.4k citations). Robert Anthony Huddart has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include David Paul Dearnaley, A. Horwich, Andrew Richard Norman, Alan Horwich, JANET M. SHIPLEY, Emma Hall, Chris C. Parker, Vincent S Khoo, Rosalind A. Eeles and Rebecca Lewis. Their work appears in journals such as Clinical Oncology, Annals of Oncology, International Journal of Radiation Oncology*Biology*Physics, British Journal of Cancer and European Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.